Clinical Trials on Ovarian Carcinoma in United States
Total 11816 results
-
Pine Street FoundationCompletedOvarian CancerUnited States
-
Duke UniversityJohns Hopkins University; Genentech, Inc.CompletedOvarian Neoplasms | Ovarian CancerUnited States
-
MorphotekCompletedEpithelial Ovarian CancerUnited States
-
Fujirebio Diagnostics, Inc.Completed
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedOvarian CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
University of ChicagoCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Fred Hutchinson Cancer CenterCompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
Stanford UniversityAstraZenecaTerminatedBladder Adenocarcinoma | Bladder Mixed Adenocarcinoma | Bladder Squamous Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma With Giant Cells | Infiltrating Bladder Urothelial Carcinoma, Nested Variant | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Bladder Urothelial... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterThe City College of New YorkCompleted
-
SanofiCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterWithdrawn
-
NYU Langone HealthNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownOvarian CancerUnited States
-
University of PennsylvaniaNational Institutes of Health (NIH)Completed
-
SanofiCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNew York University; Hadassah Medical Organization; New York Presbyterian Hospital and other collaboratorsCompletedBreast Cancer | Ovarian CancerUnited States
-
EndocyteCompletedOvary CancerCanada, United States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI); Iovance BiotherapeuticsActive, not recruitingMalignant Solid Neoplasm | Metastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Platinum-Resistant Ovarian Carcinoma | Metastatic Pancreatic Ductal Adenocarcinoma | Metastatic Ovarian Carcinoma and other conditionsUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...Massachusetts General Hospital; University of Utah; European Network of Gynaecological... and other collaboratorsCompletedOvarian CancerUnited States, Denmark
-
George Washington UniversityWithdrawn
-
Memorial Sloan Kettering Cancer CenterRecruitingOvarian Cancer | Ovarian CarcinomaUnited States
-
On Target Laboratories, LLCSynteractHCRCompletedOvarian CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Masonic Cancer Center, University of MinnesotaIncyte CorporationCompletedOvarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Yale UniversityGilead SciencesRecruitingOvarian CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
University of WashingtonMinnesota Ovarian Cancer AllianceTerminatedStage III Ovarian Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA1 Ovarian Cancer AJCC v8 | Stage IIIA2 Ovarian Cancer AJCC v8 | Stage IIIB Ovarian Cancer AJCC v8 | Stage IIIC Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IVA Ovarian Cancer AJCC v8 | Stage IVB Ovarian... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation | Infiltrating Bladder Urothelial Carcinoma With Squamous... and other conditionsUnited States
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
University of California, San FranciscoRadiological Society of North AmericaCompletedOvarian CarcinomaUnited States
-
DelMar Pharmaceuticals, Inc.WithdrawnOvarian CancerUnited States
-
South Plains Oncology ConsortiumTerminatedOvarian Cancer | Cancer of the Ovary | Primary Peritoneal Carcinoma | Ovary Neoplasms | Cancer of OvaryUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
New Mexico Cancer Care AllianceGenentech, Inc.; NYU Langone HealthCompletedOvarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Gastrointestinal Complication and other conditionsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Recurrent Endometrial Carcinoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Recurrent Uterine Sarcoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage IV Endometrial Carcinoma | Ovarian... and other conditionsUnited States
-
University of British ColumbiaGenzyme, a Sanofi CompanyTerminatedEpithelial Ovarian CancerCanada, United States
-
Prima BioMed LtdCompletedEpithelial Ovarian CancerUnited States, Australia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Nausea and Vomiting | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Stage IIA Fallopian Tube Cancer | Stage... and other conditionsUnited States